uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS
American Tower(AMT) GlobeNewswire News Room·2024-10-15 19:05American Tower(AMT) GlobeNewswire News Room·2024-10-15 19:05
R1American Tower(AMT) GlobeNewswire News Room·2024-10-15 19:05